First page of the Report "Analysis of FDA Drug GMP Warning Letters for FYs 2020 and 2021"

Report – Analysis of FDA Drug GMP Warning Letters for FYs 2020 and 2021

By

Barbara W. Unger

,

Areas examined in this report:

In-depth analysis of FDA Warning Letters issued in FY2020 and FY2021
FDA enforcement trends as indicated by this analysis
How these trends compare to enforcement trends since FY2013

If you have trouble with the form, please contact events@redica.com.

Access the white paper

If you have trouble with the form, please contact events@redica.com.